Skip to contentpushpin
Featured

Purdue Pharma Fined $5bn — Why Were No Individuals Charged?

Susan Stein 4 min read

Purdue Pharma has been sentenced to more than $5 billion in criminal penalties, yet the outcome exposes a far more uncomfortable reality about how corporate accountability actually works in large-scale cases.

Despite admitting to fraud, misleading regulators, and paying kickbacks to doctors to drive prescriptions of OxyContin, the legal resolution shows how a company can absorb enormous financial punishment while limiting the reach of individual liability.

As the settlement begins to take effect and billions start flowing into public health programmes, the structure behind the case is becoming just as important as the misconduct itself, because it reveals how similar corporate crises are likely to be handled in the future.

The Department of Justice confirmed that Purdue’s sentence includes roughly $3.5 billion in criminal fines and $2 billion in forfeiture, making it one of the largest corporate penalties ever imposed in the United States.

However, that figure sits within a much broader and more complex settlement framework often reported as exceeding $8 billion across criminal penalties, civil settlements, and bankruptcy-related payments. That wider figure also reflects separate agreements reached in broader negotiations involving the Sackler family, who have committed to contributing billions over time.

The critical point is that these numbers do not operate independently, because portions of the criminal penalties can be offset against funds already committed through bankruptcy, meaning the headline figure does not translate into a simple transfer of new money but instead forms part of a coordinated system designed to distribute funds at scale.

This structure is a direct result of Purdue’s 2019 bankruptcy filing, which consolidated thousands of lawsuits into a single legal process and allowed for a faster, more predictable resolution than traditional litigation.

Billions will now be directed toward opioid treatment, recovery programmes, and compensation for victims, and while that delivers immediate financial impact, it also reflects a deliberate trade-off built into the system.

Bankruptcy allows courts to manage mass harm efficiently, but it also creates a framework where liability can be contained, negotiated, and in some cases reduced through offsets and credits, ensuring that compensation is delivered while limiting the extent of additional financial exposure beyond what has already been agreed.

The more difficult issue, and the one that continues to define the case, is personal accountability. Only the company was charged in the criminal proceedings, and no individuals faced prosecution despite decades of control over the business and its strategy.

That outcome is closely tied to the legal boundaries reinforced by the U.S. Supreme Court in 2024, when it ruled in Harrington v. Purdue Pharma L.P. that bankruptcy cannot be used to automatically shield non-debtors from liability without consent. While that decision forced a restructuring of the settlement and prevented the broadest form of legal immunity previously sought, it did not result in criminal charges, leaving financial contributions as the primary mechanism for accountability rather than direct legal exposure.

As part of the final resolution, Purdue is expected to be replaced by a new entity structured as a public benefit corporation, with profits directed toward addressing opioid addiction and funding long-term recovery efforts. The original company will effectively cease to exist, its liabilities converted into a managed system of payments and obligations overseen through the settlement framework.

This approach closes the financial chapter of the case while also limiting the scope for further legal action against the corporate entity itself, reinforcing how large-scale settlements can bring finality even when broader questions of responsibility remain unresolved.

The Purdue case ultimately demonstrates that the legal system is capable of imposing massive financial penalties on corporations while still operating within constraints that make individual accountability far harder to achieve.

The combination of criminal sentencing, bankruptcy restructuring, and negotiated settlements creates a model that prioritises speed, coordination, and certainty, but also defines where liability stops.

That distinction is likely to shape future cases involving widespread corporate harm, because it shows that even in the most severe scenarios, the resolution may focus on financial redress rather than extending legal consequences to those behind the company. The scale of the punishment is undeniable, but the structure behind it reveals a system designed not just to penalise wrongdoing, but to manage it.

About Lawyer Monthly

Legal Intelligence. Trusted Insight. Since 2010
Work With Us

Follow Lawyer Monthly